Subjects With Mild Hypertriglyceridemia in Type 2 DM Clinical Trial
Verified date | February 2013 |
Source | Yonsei University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Korea: Institutional Review Board |
Study type | Interventional |
We examined whether a substitution of whole grains and legumes for refined rice in a high carbohydrate diet (about 65% of energy derived from carbohydrate) may modify the effect of this variant on changes in apolipoprotein A-V (apoA-V) and triglyceride concentrations.
Status | Completed |
Enrollment | 200 |
Est. completion date | October 2012 |
Est. primary completion date | June 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 25 Years to 72 Years |
Eligibility |
Inclusion Criteria: - Subjects who were in in impaired fasting glucose (IFG, 100= fasting glucose <126 mg/dL) and newly diagnosed type 2 diabetes (fasting glucose =126 mg/dL) were referred to the Department of Family Medicine or Internal Medicine. They were rechecked for their health and lipid profiles, and then those who satisfied the study criteria were recommended to participate in the dietary intervention program Exclusion Criteria: - Current and/or past history of cardiovascular disease including angina - Liver or kidney dysfunction - Thyroid or pituitary disease - Unstable weight loss/gain (=2 kg) over the previous 6months - Pregnancy or lactation. Subjects who were taking medication were also excluded |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Yonsei university | Seoul |
Lead Sponsor | Collaborator |
---|---|
Yonsei University |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Apolipoprotein A5 gene | ApoA5 -1131T>C polymorphism | Yes | |
Primary | Triglyceride | change from baseline in TG at 12 weeks | Yes | |
Secondary | Apolipoprotein A5 | Change from baseline in ApoA5 at 12 weeks | Yes |